Logo image of MAZ-H.CA

MAZARIN INC (MAZ-H.CA) Stock Fundamental Analysis

TSX-V:MAZ-H - TSX Venture Exchange - CA5789011007 - Common Stock - Currency: CAD

0.13  0 (0%)

Fundamental Rating

5

MAZ-H gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. MAZ-H has an average financial health and profitability rating. MAZ-H has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MAZ-H had positive earnings in the past year.
In the past year MAZ-H had a positive cash flow from operations.
In multiple years MAZ-H reported negative net income over the last 5 years.
MAZ-H had negative operating cash flow in 4 of the past 5 years.
MAZ-H.CA Yearly Net Income VS EBIT VS OCF VS FCFMAZ-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

The Return On Assets of MAZ-H (5.61%) is better than 92.12% of its industry peers.
The Return On Equity of MAZ-H (29.50%) is better than 97.09% of its industry peers.
The Return On Invested Capital of MAZ-H (13.78%) is better than 96.85% of its industry peers.
Industry RankSector Rank
ROA 5.61%
ROE 29.5%
ROIC 13.78%
ROA(3y)2.07%
ROA(5y)1.47%
ROE(3y)13.36%
ROE(5y)10.09%
ROIC(3y)N/A
ROIC(5y)N/A
MAZ-H.CA Yearly ROA, ROE, ROICMAZ-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

MAZ-H's Profit Margin of 21.56% is amongst the best of the industry. MAZ-H outperforms 96.85% of its industry peers.
MAZ-H's Profit Margin has declined in the last couple of years.
MAZ-H has a better Operating Margin (55.05%) than 99.27% of its industry peers.
MAZ-H's Operating Margin has declined in the last couple of years.
MAZ-H has a better Gross Margin (77.33%) than 98.55% of its industry peers.
MAZ-H's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 55.05%
PM (TTM) 21.56%
GM 77.33%
OM growth 3Y343.65%
OM growth 5Y-22.14%
PM growth 3YN/A
PM growth 5Y-20.96%
GM growth 3Y11.27%
GM growth 5Y-15.16%
MAZ-H.CA Yearly Profit, Operating, Gross MarginsMAZ-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 150

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MAZ-H is creating some value.
Compared to 1 year ago, MAZ-H has more shares outstanding
Compared to 5 years ago, MAZ-H has more shares outstanding
MAZ-H has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MAZ-H.CA Yearly Shares OutstandingMAZ-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAZ-H.CA Yearly Total Debt VS Total AssetsMAZ-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

MAZ-H has an Altman-Z score of 0.85. This is a bad value and indicates that MAZ-H is not financially healthy and even has some risk of bankruptcy.
MAZ-H's Altman-Z score of 0.85 is in line compared to the rest of the industry. MAZ-H outperforms 51.39% of its industry peers.
MAZ-H has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.85
ROIC/WACC1.49
WACC9.25%
MAZ-H.CA Yearly LT Debt VS Equity VS FCFMAZ-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

2.3 Liquidity

MAZ-H has a Current Ratio of 1.97. This is a normal value and indicates that MAZ-H is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.97, MAZ-H perfoms like the industry average, outperforming 56.61% of the companies in the same industry.
MAZ-H has a Quick Ratio of 1.97. This is a normal value and indicates that MAZ-H is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.97, MAZ-H perfoms like the industry average, outperforming 58.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.97
MAZ-H.CA Yearly Current Assets VS Current LiabilitesMAZ-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

MAZ-H shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.31%, which is quite impressive.
Measured over the past years, MAZ-H shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.73% on average per year.
Looking at the last year, MAZ-H shows a very strong growth in Revenue. The Revenue has grown by 158.90%.
MAZ-H shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.29% yearly.
EPS 1Y (TTM)89.31%
EPS 3YN/A
EPS 5Y-8.73%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)158.9%
Revenue growth 3Y32.95%
Revenue growth 5Y17.29%
Sales Q2Q%98.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MAZ-H.CA Yearly Revenue VS EstimatesMAZ-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
MAZ-H.CA Yearly EPS VS EstimatesMAZ-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

5

4. Valuation

4.1 Price/Earnings Ratio

MAZ-H is valuated cheaply with a Price/Earnings ratio of 2.60.
MAZ-H's Price/Earnings ratio is rather cheap when compared to the industry. MAZ-H is cheaper than 98.42% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. MAZ-H is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.6
Fwd PE N/A
MAZ-H.CA Price Earnings VS Forward Price EarningsMAZ-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAZ-H is valued cheaply inside the industry as 99.88% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MAZ-H is valued cheaper than 93.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.84
EV/EBITDA 0.43
MAZ-H.CA Per share dataMAZ-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

The decent profitability rating of MAZ-H may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MAZ-H!.
Industry RankSector Rank
Dividend Yield N/A

MAZARIN INC

TSX-V:MAZ-H (3/3/2025, 7:00:00 PM)

0.13

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners29.75%
Ins Owner ChangeN/A
Market Cap6.53M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.6
Fwd PE N/A
P/S 0.61
P/FCF 23.84
P/OCF 112.63
P/B 0.83
P/tB 0.83
EV/EBITDA 0.43
EPS(TTM)0.05
EY38.46%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY4.19%
OCF(TTM)0
OCFY0.89%
SpS0.21
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.61%
ROE 29.5%
ROCE 16.23%
ROIC 13.78%
ROICexc 14.75%
ROICexgc 14.75%
OM 55.05%
PM (TTM) 21.56%
GM 77.33%
FCFM 2.55%
ROA(3y)2.07%
ROA(5y)1.47%
ROE(3y)13.36%
ROE(5y)10.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y462.61%
ROICexcg growth 5Y-11.51%
ROICexc growth 3Y462.61%
ROICexc growth 5Y-11.51%
OM growth 3Y343.65%
OM growth 5Y-22.14%
PM growth 3YN/A
PM growth 5Y-20.96%
GM growth 3Y11.27%
GM growth 5Y-15.16%
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 218.18%
Cap/Sales 2.01%
Interest Coverage 250
Cash Conversion 0.96%
Profit Quality 11.81%
Current Ratio 1.97
Quick Ratio 1.97
Altman-Z 0.85
F-Score6
WACC9.25%
ROIC/WACC1.49
Cap/Depr(3y)3396.81%
Cap/Depr(5y)2068.08%
Cap/Sales(3y)9.99%
Cap/Sales(5y)6.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.31%
EPS 3YN/A
EPS 5Y-8.73%
EPS Q2Q%-38.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)158.9%
Revenue growth 3Y32.95%
Revenue growth 5Y17.29%
Sales Q2Q%98.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y325.2%
EBIT growth 3Y489.83%
EBIT growth 5Y-8.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y211.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.73%
OCF growth 3YN/A
OCF growth 5YN/A